OneThree Biotech
New York
About OneThree Biotech
OneThree Biotech redesigns drug discovery with biology-driven artificial intelligence to uncover new insights. Its platform predicts new potential therapeutics and pinpoints the mechanisms driving efficacy. It also integrates over 30 types of chemical, biological, and clinical data for each task that leads to a significant increase in accuracy, interpretability, and chance of clinical success. OneThree Biotech was founded in 2018 and is headquartered in New York, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: Seed
- Last round: Seed (Mar 2020)
- Website: onethree.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Genetics, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/onethree-biotech-2337 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.